GLOBUS MEDICAL INC (GMED) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for GLOBUS MEDICAL INC (GMED): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 73/100 — a percentile rank of GLOBUS MEDICAL INC’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.
| Market cap | $10.0B |
| P / E | 18.7× |
| P / S | 3.2× |
| EV / EBITDA | 9.9× |
| Gross margin | 68.5% |
| Operating margin | 20.3% |
| Net margin | 17.0% |
| Return on equity | 11.2% |
| ROIC | 12.2% |
| Revenue growth | 19.7% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Is GLOBUS MEDICAL INC overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from GLOBUS MEDICAL INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact